Your browser doesn't support javascript.
loading
Immunohistochemical Characterization of the IL-13:IL-4 Receptor α Axis in the Skin of Adult Patients with Moderate to Severe Atopic Dermatitis and Healthy Controls.
Miranda, Elena; Roberts, Jennifer; Novick, Steven; Lapointe, Jean-Martin; Bruijnzeel-Koomen, Carla; Thijs, JudithL; Sleeman, Matthew A; May, Richard D; Hijnen, DirkJan; Strickland, Ian.
Afiliação
  • Miranda E; BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, United Kingdom. Electronic address: elenamiranda026@gmail.com.
  • Roberts J; BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, United Kingdom.
  • Novick S; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Lapointe JM; BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, United Kingdom.
  • Bruijnzeel-Koomen C; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Thijs J; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sleeman MA; BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, United Kingdom.
  • May RD; BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, United Kingdom.
  • Hijnen D; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Strickland I; BioPharmaceuticals R&D, AstraZeneca, Granta Park, Cambridge, United Kingdom.
J Invest Dermatol ; 141(2): 440-443.e4, 2021 02.
Article em En | MEDLINE | ID: mdl-32598926

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Interleucina-13 / Dermatite Atópica / Subunidade alfa de Receptor de Interleucina-4 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Interleucina-13 / Dermatite Atópica / Subunidade alfa de Receptor de Interleucina-4 Idioma: En Ano de publicação: 2021 Tipo de documento: Article